MICHELE REYNOLDS: Open Payments
NPI 1801042247 · PINE BLUFF, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 34 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $309 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $164 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
| Lundbeck LLC | 2 | $31 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, CAPLYTA, SPRAVATO, ABILIFY MAINTENA, HETLIOZ, Qelbree, FANAPT, VRAYLAR.
Industry payments across AR — which companies pay providers there.
